Israel Englander’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Israel Englander’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,565	Closed	-$190K	–	7811
2021 Q4	$190K	Sell	1,565 -11,080	-88%	-$1.87M	﹤0.01%	5941
2021 Q3	$1.78M	Buy	+12,645	New	+$2.51M	﹤0.01%	4059

Other funds holding EVLO

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Israel Englander's EVLO Position: Q4 2023 in Review

Israel Englander sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 38,093 shares — an estimated $149K sold.

Israel Englander first reported a position in EVLO in Q1 2020 and held it in 14 quarters. The position peaked at $1.33M in Q1 2021. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

Israel Englander reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Israel Englander sold 38,093 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $149K.
Israel Englander first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
Israel Englander's Evelo Biosciences, Inc. Common Stock position peaked at $1.33M in Q1 2021.
2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.